Follow Us
© 2026 Arizent. All rights reserved.
Hasday is president of Frenkel Benefits, an EPIC company, a major independent employee benefit broker.
For reprint and licensing requests for this article, click here.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
A look at traditional PBMs and pass-through models, potential savings areas, developments and partnering with the right consultant.
Part one of this two-part series looks at the background, transparency solutions and how to understand PBM profitability.
Full disclosure of administrative fees, rebates and spread pricing practices is essential to ensure PBM incentives align with a client's best interests.
High-priced treatments, administered in expensive facilities, are becoming one of the largest cost drivers within prescription plans.
